This statistic shows the leading drugs that will go off patent in 2017 in the U.S., by 2016 revenue, in million U.S. dollars. In 2017, Pfizer's Viagra, which generated U.S. revenues of some *** billion dollars in 2016, will go off patent. When pharmaceutical drugs lose their patents it is possible for drug makers to make generic versions of the drug.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Evaluate, & Vantage. (December 30, 2016). Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)* [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 22, 2026, from /statistics/626844/leading-drugs-going-generic-revenue/
Evaluate, und Vantage. "Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*." Chart. December 30, 2016. ÌÇÐÄÆÆ½â°æ. Accessed July 22, 2026. /statistics/626844/leading-drugs-going-generic-revenue/
Evaluate, Vantage. (2016). Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 22, 2026. /statistics/626844/leading-drugs-going-generic-revenue/
Evaluate, and Vantage. "Leading Drugs Going off Patent in The U.S. in 2017, by Revenue (in Million U.S. Dollars)*." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 30 Dec 2016, /statistics/626844/leading-drugs-going-generic-revenue/
Evaluate & Vantage, Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)* ÌÇÐÄÆÆ½â°æ, /statistics/626844/leading-drugs-going-generic-revenue/ (last visited July 22, 2026)
Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)* [Graph], Evaluate, & Vantage, December 30, 2016. [Online]. Available: /statistics/626844/leading-drugs-going-generic-revenue/